2024-02-01 2025-01-31 false Capium Accounts Production 1.1 14591726 2024-02-01 2025-01-31 14591726 bus:AbridgedAccounts 2024-02-01 2025-01-31 14591726 bus:FRS102 2024-02-01 2025-01-31 14591726 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 14591726 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 14591726 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 14591726 2024-02-01 2025-01-31 14591726 2025-01-31 14591726 bus:RegisteredOffice 2024-02-01 2025-01-31 14591726 core:WithinOneYear 2025-01-31 14591726 core:AfterOneYear 2025-01-31 14591726 1 2024-02-01 2025-01-31 14591726 bus:Director1 2024-02-01 2025-01-31 14591726 bus:Director1 2025-01-31 14591726 bus:Director1 2023-01-13 2024-01-31 14591726 bus:Director2 2024-02-01 2025-01-31 14591726 bus:Director2 2025-01-31 14591726 bus:Director2 2023-01-13 2024-01-31 14591726 bus:Director3 2024-02-01 2025-01-31 14591726 bus:Director3 2025-01-31 14591726 bus:Director3 2023-01-13 2024-01-31 14591726 bus:Director4 2024-02-01 2025-01-31 14591726 bus:Director4 2025-01-31 14591726 bus:Director4 2023-01-13 2024-01-31 14591726 2023-01-13 14591726 bus:LeadAgentIfApplicable 2024-02-01 2025-01-31 14591726 2023-01-13 2024-01-31 14591726 2024-01-31 14591726 core:WithinOneYear 2024-01-31 14591726 core:AfterOneYear 2024-01-31 14591726 bus:EntityAccountantsOrAuditors 2023-01-13 2024-01-31 14591726 core:MotorCars 2024-02-01 2025-01-31 14591726 core:MotorCars 2025-01-31 14591726 core:MotorCars 2024-01-31 14591726 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-31 14591726 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-01-31 14591726 core:NetGoodwill 2024-02-01 2025-01-31 14591726 core:NetGoodwill 2025-01-31 14591726 core:NetGoodwill 2024-01-31 14591726 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 14591726 core:CostValuation core:Non-currentFinancialInstruments 2024-01-31 14591726 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-01-31 14591726 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 14591726 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 14591726 core:Non-currentFinancialInstruments 2025-01-31 14591726 core:Non-currentFinancialInstruments 2024-01-31 14591726 core:RetainedEarningsAccumulatedLosses 2025-01-31 14591726 core:RetainedEarningsAccumulatedLosses 2024-01-31 14591726 dpl:Item1 2024-02-01 14591726 dpl:Item1 2025-01-31 14591726 dpl:Item1 2023-01-13 14591726 dpl:Item1 2024-01-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 14591726
PILLCARE PHARMA LIMITED
Abridged Accounts
Period of accounts Start date: 01 February 2024 End date: 31 January 2025

PILLCARE PHARMA LIMITED Contents Page For the year ended 31 January 2025
Accountants' report | 1
Statement of financial position | 2
Notes to the financial statements | 3

PILLCARE PHARMA LIMITED Accountants' Report For the year ended 31 January 2025
Accountant’s report You consider that the company is exempt from an audit for the year ended 31 January 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. Myrtle Gund Ltd 31 January 2025 .................................................... Myrtle Gund Ltd 248 Lockwood Road Huddersfield HD1 3TG 19 February 2026 1

PILLCARE PHARMA LIMITED Statement of Financial Position As at 31 January 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Intangible fixed assets | 3 | 1,332,070 |  | 1,404,663
Tangible fixed assets | 4 | 14,062 |  | 0
|  | 1,346,132 |  | 1,404,663
Current assets |  |  |
Stocks |  | 90,000 |  | 90,000
Debtors |  | 361,548 |  | 317,859
Cash at bank and in hand |  | 746,955 |  | 164,619
|  | 1,198,503 |  | 572,478
Creditors: amount falling due within one year |  | (1,029,485) |  | (492,709)
Net current assets |  | 169,018 |  | 79,769
Total assets less current liabilities |  | 1,515,150 |  | 1,484,432
Creditors: amount falling due after more than one year |  | (1,485,478) |  | (1,450,478)
Net assets |  | 29,672 |  | 33,954
Capital and reserves |  |  |
Profit and loss account |  | 29,672 |  | 33,954
Shareholders' funds |  | 29,672 |  | 33,954
For the year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the board of directors on 19 February 2026 and were signed on its behalf by:
------------------------------- Amit Aggarwal Director
2

PILLCARE PHARMA LIMITED Notes to the Abridged Financial Statements For the year ended 31 January 2025
General Information PILLCARE PHARMA LIMITED is a private company, limited by shares, registered in , registration number 14591726, registration address 14 OXCLOSE PARK RISE, HALFWAY SHEFFIELD, S20 8GW. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company.
2. | Average number of employees Average number of employees during the year was 20 (2024 : 17).
3. | Intangible fixed assets
Cost | Goodwill |  | Total
| £ |  | £
At 01 February 2024 | 1,447,902 |  | 1,447,902
Additions | - |  | -
Disposals | - |  | -
At 31 January 2025 | 1,447,902 |  | 1,447,902
Amortisation
At 01 February 2024 | 43,239 |  | 43,239
Charge for year | 72,593 |  | 72,593
On disposals | - |  | -
At 31 January 2025 | 115,832 |  | 115,832
Net book values
At 31 January 2025 | 1,332,070 |  | 1,332,070
At 31 January 2024 | 1,404,663 |  | 1,404,663
4. | Tangible fixed assets
Cost or valuation | Motor Vehicles |  | Total
| £ |  | £
At 01 February 2024 | - |  | -
Additions | 15,495 |  | 15,495
Disposals | - |  | -
At 31 January 2025 | 15,495 |  | 15,495
Depreciation
At 01 February 2024 | - |  | -
Charge for year | 1,433 |  | 1,433
On disposals | - |  | -
At 31 January 2025 | 1,433 |  | 1,433
Net book values
Closing balance as at 31 January 2025 | 14,062 |  | 14,062
Opening balance as at 01 February 2024 | - |  | -
3